Exact Mass: 303.18343400000003
Exact Mass Matches: 303.18343400000003
Found 105 metabolites which its exact mass value is equals to given mass value 303.18343400000003
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-Lauroyl Cysteine
N-lauroyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Lauric acid amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Lauroyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Lauroyl Cysteine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Aptiganel
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents
(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-methoxy-2-phenylpropanoate
C18H25NO3 (303.18343400000003)
(+-)-N-Methyloreolin|(??)-Oridine|N-Methyl-oreolin|N-Methyl-oridin|N-Methyloreolin
C18H25NO3 (303.18343400000003)
(2R,2S)-3-(2,3-Dihydroxy-3-methylbutyl)-5-(2,3-epoxy-3-methylbutyl)indole
C18H25NO3 (303.18343400000003)
(-)-suaveoline|(6S,13S)-4-ethyl-6,7,12,13-tetrahydro-7-methyl-6,13-imino-5H-pyrido[3,4:5,6]cyclooct[1,2-b]indole|4-ethyl-7-methyl-6,7,12,13-tetrahydro-5H-6,13-epiazano-pyrido[3,4:5,6]cycloocta[1,2-b]indole|Suaveolin|suaveoline|Suaveoline +
(-)-berkeleyamide A|(10S,11R,14S)-berkeleyamide A|berkeleyamide A
C18H25NO3 (303.18343400000003)
(-)-3-methoxy-4-O-methyljoubertiamine|(S)-3-Methoxy-4-O-methyljoubertiamine|O-methyljoubertiamine
C18H25NO3 (303.18343400000003)
(2E)-N-isobutyl-7-(3,4-methylenedioxy)phenylheptenenamide|(2E)-N-isobutyl-7-(3,4-methylenedioxyphenyl)hepta-2-enamide|Pipercallosidine
C18H25NO3 (303.18343400000003)
10-O-demethylproemethine|10-O-demethylprotoemetine
C18H25NO3 (303.18343400000003)
3-hydroxy-3-nonyl-1H-quinoline-2,4-dione
C18H25NO3 (303.18343400000003)
C18H25NO3_2-Heptenamide, 7-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)-, (2E)
C18H25NO3 (303.18343400000003)
TERT-BUTYL SPIRO[ISOCHROMAN-1,4-PIPERIDINE]-1-CARBOXYLATE
C18H25NO3 (303.18343400000003)
tert-Butyl 3-hydroxyspiro[indan-1,4-piperidine]-1-carboxylate
C18H25NO3 (303.18343400000003)
N-Methyl-3-pyrrolidinyl Cyclopentylmandelate
C18H25NO3 (303.18343400000003)
tert-Butyl 4-(4-methylbenzoyl)piperidine-1-carboxylate
C18H25NO3 (303.18343400000003)
Methyl (8-benzyl-1-oxa-8-azaspiro[4.5]dec-2-yl)acetate
C18H25NO3 (303.18343400000003)
3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]decan-2-one
C18H25NO3 (303.18343400000003)
butyl prop-2-enoate, prop-2-enamide, styrene
C18H25NO3 (303.18343400000003)
Pipercallosidine
C18H25NO3 (303.18343400000003)
An enamide that is (2E)-N-isobutylhept-2-enamide which is substituted at position 7 by a 3,4-methylenedioxyphenyl group. A natural product found in Piper sarmentosum.
Leu-Thr-Ala
A tripeptide composed of L-leucine, L-threonine and L-alanine joined in sequence by peptide linkages.
9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate
(8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoate
1-Butyl-5-hydroxy-3-methoxycarbonyl-2,4,6,7-tetramethylindole
C18H25NO3 (303.18343400000003)
Aptiganel
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents
oscr#10(1-)
A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#10, obtained by deprotonation of the carboxy group; major species at pH 7.3.
ascr#10(1-)
A monocarboxylic acid anion resulting from the deprotonation of the carboxy group of ascr#10. The conjugate base of ascr#10 and the major species at pH 7.3.
17-ethyl-3-methyl-3,15,20-triazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,13(18),14,16-heptaene
(1s,15r,16r,21s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,12-hexaene
1-{5-[(3,3-dimethyloxiran-2-yl)methyl]-1h-indol-3-yl}-3-methylbutane-2,3-diol
C18H25NO3 (303.18343400000003)
(2s,11bs)-2-[(2r)-1-hydroxybut-3-en-2-yl]-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol
C18H25NO3 (303.18343400000003)
(2s,11bs)-2-[(2s)-1-hydroxybut-3-en-2-yl]-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol
C18H25NO3 (303.18343400000003)
(4s)-4-[(3r,5r)-5-[(2s)-butan-2-yl]-2-hydroxy-4,5-dihydro-3h-pyrrol-3-yl]-4-hydroxy-1-phenylbutan-2-one
C18H25NO3 (303.18343400000003)
(4s)-4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-one
C18H25NO3 (303.18343400000003)
4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene
7-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hept-2-enimidic acid
C18H25NO3 (303.18343400000003)
(2r)-1-(5-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-1h-indol-3-yl)-3-methylbutane-2,3-diol
C18H25NO3 (303.18343400000003)
2-[(2r,3r,11bs)-3-ethyl-10-hydroxy-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]acetaldehyde
C18H25NO3 (303.18343400000003)
(2e)-4-[(1s,3r,4s,7s)-4-hexyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]dec-8-en-10-ylidene]but-2-enoic acid
C18H25NO3 (303.18343400000003)
(2e)-7-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)hept-2-enimidic acid
C18H25NO3 (303.18343400000003)
(4s)-4-hydroxy-4-[(3r,5s)-2-hydroxy-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-3-yl]-1-phenylbutan-2-one
C18H25NO3 (303.18343400000003)
2-(1-hydroxybut-3-en-2-yl)-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-10-ol
C18H25NO3 (303.18343400000003)
(1r,15r,16s)-4,14,20-triazahexacyclo[13.6.2.0²,¹⁴.0³,¹¹.0⁵,¹⁰.0¹⁶,²¹]tricosa-2,4,6,8,10,20-hexaene
(1s,10s,11r,13s,15r)-15-methyl-14-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadec-2-en-11-yl acetate
C18H25NO3 (303.18343400000003)
4-(3,4-dimethoxyphenyl)-4-[2-(dimethylamino)ethyl]cyclohex-2-en-1-one
C18H25NO3 (303.18343400000003)
4-hydroxy-4-[2-hydroxy-5-(2-methylpropyl)-4,5-dihydro-3h-pyrrol-3-yl]-1-phenylbutan-2-one
C18H25NO3 (303.18343400000003)
2-{3-ethyl-10-hydroxy-9-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}acetaldehyde
C18H25NO3 (303.18343400000003)